Close
Nordic 9Nordic 9

VDL Groep (investor - Corporate Investor)

Netherlands
See something wrong or missing? Let us know
Offices:Eindhoven
Average round investment:2.27M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Netherlands VitalFluid
Mostly invests in: Netherlands Netherlands (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to VDL Groep

Name Criteria
Netherlands C4 holding BV
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Utrecht Holdings
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Borski Fund
82%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
France Advent France Biotechnology
80%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Axilium Capital
80%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Linc Invest
80%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Rhia Ventures
80%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Wealth Club
80%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Wren Capital
80%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Orange Light Ventures
80%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top